Skip to main content
logo
Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.670
-0.550 (-17.08%)
Aug 19, 2026, 4:00 PM EDT - Market closed

Intelligent Bio Solutions Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
-12.43-10.57-10.16-10.63-8.31
Depreciation & Amortization
1.161.211.210.97-
Asset Writedown & Restructuring Costs
0.30.22-4.162.6
Stock-Based Compensation
0.20.240.230.26-
Provision & Write-off of Bad Debts
0.0100.01--
Other Operating Activities
0.06-0.06-0.16-2.21-0.09
Change in Accounts Receivable
-0.25-0.16-0.14-0.29-
Change in Inventory
0.220.140.2-0.35-
Change in Accounts Payable
-0.682.58-0.630.080.24
Change in Other Net Operating Assets
-0.5-3.28-0.140.632.2
Operating Cash Flow
-11.93-9.68-9.57-7.38-3.36
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-0.13-0.23-0.22-0.51-0.38
Sale of Property, Plant & Equipment
0.04----
Cash Acquisitions
----0.19-
Other Investing Activities
-----0.5
Investing Cash Flow
-0.09-0.23-0.22-0.69-0.88

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Issuance of Common Stock
14.984.614.562.55-
Repurchase of Common Stock
----0.01-
Other Financing Activities
----1.33-
Financing Cash Flow
14.984.614.561.44-

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
00.03-0-0.06-0.1
Net Cash Flow
2.97-5.284.77-6.7-4.34

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-12.05-9.91-9.79-7.88-3.74
Free Cash Flow Growth
-----
Free Cash Flow Margin
-285.94%-324.62%-314.71%-627.15%-
Free Cash Flow Per Share
-8.18-18.79-61.48--
Levered Free Cash Flow
-7.06-5.8-5.87-3.67-1.56
Unlevered Free Cash Flow
-7.05-5.76-5.76-3.53-1.56

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Change in Working Capital
-1.23-0.72-0.70.082.44
SEC Filings: 10-K · 10-Q